Zimmer Biomet Appoints Kevin Thornal as Group President

Zimmer Biomet Holdings ( (ZBH) ) has provided an announcement.

On May 27, 2025, Zimmer Biomet Holdings announced the appointment of Kevin Thornal as Group President, Global Businesses and the Americas, effective July 1, 2025. Thornal, who previously served as CEO of Nevro Corp., brings extensive experience in the medical technology, orthopedics, and diagnostics industries. His leadership is expected to enhance Zimmer Biomet’s commercial execution and stakeholder value, as the company aims to address unmet needs in musculoskeletal health and expand its product pipeline.

The most recent analyst rating on (ZBH) stock is a Buy with a $135.00 price target. To see the full list of analyst forecasts on Zimmer Biomet Holdings stock, see the ZBH Stock Forecast page.

Spark’s Take on ZBH Stock

According to Spark, TipRanks’ AI Analyst, ZBH is a Outperform.

Zimmer Biomet Holdings exhibits strong financial performance with consistent growth and robust cash flows. Technical analysis signals some caution due to bearish trends. Valuation appears reasonable, though not overly attractive. The earnings call indicated solid operational performance but highlighted some challenges impacting near-term financial guidance. Overall, the company remains well-positioned in the Medical Devices industry, but investors should be mindful of potential headwinds.

To see Spark’s full report on ZBH stock, click here.

More about Zimmer Biomet Holdings

Zimmer Biomet is a global leader in medical technology, offering a comprehensive portfolio aimed at maximizing mobility and improving health. The company is known for its innovative products and integrated digital and robotic technologies that utilize data analytics and artificial intelligence. With over 90 years of experience, Zimmer Biomet operates in more than 25 countries and sells in over 100 countries, maintaining a strong legacy of evolution and innovation.

Average Trading Volume: 2,352,839

Technical Sentiment Signal: Sell

Current Market Cap: $18.33B

For an in-depth examination of ZBH stock, go to TipRanks’ Stock Analysis page.